Author Archives for Adeline Chauvigné

ABYS® MEDICAL successfully completes its first Series A of €3 million

6 December 2021

Abys® Medical, deeptech creator of the Surgery 4.0 concept, finalized in August 2021 a fundraising by opening its capital to... View Article

Valneva confirms initiation of rolling review with EMA and provides updates on its COVID-19 vaccine program VLA2001

6 December 2021

Valneva, a specialty vaccine company, today confirmed that the European Medicines Agency (EMA) has started a rolling review of VLA2001,... View Article

Pherecydes Pharma strengthens its intellectual property with the first patent granted in Israel

6 December 2021

Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces that... View Article

OSE Immunotherapeutics Provides an Update on the First Positive Results and Clinical Development of CoVepiT, its Multi-Target T-cell Anti-COVID Vaccine

6 December 2021

New clinical data confirm the good tolerance of CoVepiT and a very good level of T cell response in healthy... View Article

Valneva signs purchase agreement with European Commission for its inactivated COVID-19 vaccine VLA2001

6 December 2021

Valneva, a specialty vaccine company, today announced that it has signed an Advance Purchase Agreement (APA) with the European Commission... View Article

New member | Dopharma

6 December 2021

DOPHARMA France is a veterinary pharmaceutical company, installed in Vair-sur-Loire (France, 44) for more than 50 years. Through its historical... View Article

Owkin becomes ‘unicorn’ with $180m investment from Sanofi and four new collaborative projects

6 December 2021

Owkin and Sanofi are delighted to announce that Owkin is now a ‘unicorn’ – a startup valued at more than... View Article

OSE Immunotherapeutics and the FoRT Foundation Announce First Patient Randomized in Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Opdivo® (nivolumab) in Non-Small Cell Lung Cancer

6 December 2021

Clinical trial sponsored and conducted by the Italian Oncology Foundation FoRT and supported by Bristol Myers Squibb and OSE Immunotherapeutics.... View Article

World first: a double forearm transplant thanks to marina lugworms from the company Hemarina

6 December 2021

Amrita Institute of Medical Sciences (AIMS) in Kochi, India, Becomes the First Hospital in the World to Carry Out Bilateral... View Article

Healthcare sovereignty is closely linked to industrial recovery!

6 December 2021

The key issue of the Plan France 2030 centres on restoring French sovereignty in certain strategic areas in order to... View Article